November 17, 2025
Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies
November 14, 2025
New Global Alliance ALIGN-T1D Commits to Transforming Diabetes Care in Low- and Middle-Income Countries
November 13, 2025
Breakthrough T1D Honors World Diabetes Day with “The State of T1D”
November 13, 2025
Breakthrough T1D, the Leading Global Type 1 Diabetes Research and Advocacy Organization, Expresses Gratitude for Extension of Special Diabetes Program
November 6, 2025
Breakthrough T1D Encouraged by Promising Results of FINE-ONE Phase 3 Clinical Trial Evaluating Finerenone for Chronic Kidney Disease Associated with Type 1 Diabetes
October 30, 2025
Breakthrough T1D Launches “See T1D”, a Nationwide Ad Campaign Spotlighting Life with Type 1 Diabetes in Honor of National Diabetes Awareness Month
October 30, 2025
Breakthrough T1D Applauds Launch of Lilly’s Phase 3 Clinical Trials
October 16, 2025
Breakthrough T1D Congratulates Civica on Launch of its First Low-Cost, Long-Acting Insulin
October 7, 2025
DEKA Research & Development Completes Acquisition of Diatech Diabetes Core Assets and IP
October 1, 2025
Breakthrough T1D Kicks Off Fall Walks to Celebrate Community and Raise Funds for Type 1 Diabetes Research
